Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss… Reuters Nov 5, 2024 The move taps into surging demand for appetite-suppressing GLP-1 agonists, set against ongoing shortages of newer weight-loss…
Cipla receives final approval for generic version of Shire’s Firazyr EP News Bureau Jul 14, 2020 Icatibant injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and…
Claris settles patent case with Fresenius Kabi over Diprivan generic Usha Sharma Apr 21, 2015 In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its ANDA for Propofol
